Advice
Following a full submission
clostridium botulinum neurotoxin type A (Xeomin) is accepted for use within NHS Scotland for the symptomatic management of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) in adults.
For both indications, a similar improvement in symptoms has been shown compared to another clostridium botulinum neurotoxin type A.
Download detailed advice87KB (PDF)
Medicine details
- Medicine name:
- botulinum neurotoxin type A (Xeomin)
- SMC ID:
- 464/08
- Indication:
- symptomatic management of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) in adults
- Pharmaceutical company
- Merz Pharma UK Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 09 June 2008